Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A role for the mu opioid receptor in the antidepressant effects of buprenorphine
Shivon A. Robinson, Rebecca L. Erickson, Caroline A. Browne, et al.
Behavioural Brain Research (2016) Vol. 319, pp. 96-103
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression
Eleni Pitsillou, Sarah M. Bresnehan, Evan A. Kagarakis, et al.
Molecular Biology Reports (2019) Vol. 47, Iss. 1, pp. 753-770
Closed Access | Times Cited: 157
The nuts and bolts of animal emotion
Louise Kremer, S.E.J. Klein Holkenborg, Inonge Reimert, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 273-286
Open Access | Times Cited: 155
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 2
Opioid system and human emotions
Lauri Nummenmaa, Lauri Tuominen
British Journal of Pharmacology (2017) Vol. 175, Iss. 14, pp. 2737-2749
Open Access | Times Cited: 145
A standardization of the Novelty-Suppressed Feeding Test protocol in rats
Arantxa Blasco‐Serra, Eva María González-Soler, Ana Cervera‐Ferri, et al.
Neuroscience Letters (2017) Vol. 658, pp. 73-78
Closed Access | Times Cited: 95
Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans
Anya K. Bershad, Melissa A. Miller, Greg J. Norman, et al.
Hormones and Behavior (2018) Vol. 102, pp. 41-47
Open Access | Times Cited: 87
Targeting opioid dysregulation in depression for the development of novel therapeutics
Caroline A. Browne, Irwin Lucki
Pharmacology & Therapeutics (2019) Vol. 201, pp. 51-76
Open Access | Times Cited: 84
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
Lauri Nummenmaa, Tomi Karjalainen, Janne Isojärvi, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1953-1959
Open Access | Times Cited: 68
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Moriah L. Jacobson, Caroline A. Browne, Irwin Lucki
The Annual Review of Pharmacology and Toxicology (2020) Vol. 60, Iss. 1, pp. 615-636
Closed Access | Times Cited: 56
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder
Jean M. Bidlack, Brian I. Knapp, Daniel R. Deaver, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 367, Iss. 2, pp. 267-281
Open Access | Times Cited: 57
Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine
Caroline A. Browne, Edgardo Falcón, Shivon A. Robinson, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 21, Iss. 2, pp. 164-174
Open Access | Times Cited: 53
Palmitoylation as a Functional Regulator of Neurotransmitter Receptors
В. С. Науменко, Evgeni Ponimaskin
Neural Plasticity (2018) Vol. 2018, pp. 1-18
Open Access | Times Cited: 50
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
Shane W Kaski, Allison White, Joshua Gross, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 487-499
Open Access | Times Cited: 43
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 4, pp. 455-466
Open Access | Times Cited: 37
Involvement of opioid system in behavioral despair induced by social isolation stress in mice
Arvin Haj‐Mirzaian, Rajan Nikbakhsh, Kiana Ramezanzadeh, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 938-944
Open Access | Times Cited: 44
The opioid system and the social brain: implications for depression and suicide
Pierre‐Eric Lutz, Philippe Courtet, Raffaella Calati
Journal of Neuroscience Research (2018) Vol. 98, Iss. 4, pp. 588-600
Open Access | Times Cited: 42
In vivo electrophysiological recordings of the effects of antidepressant drugs
Paul J. Fitzgerald, Brendon O. Watson
Experimental Brain Research (2019) Vol. 237, Iss. 7, pp. 1593-1614
Open Access | Times Cited: 40
Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine
Lucja Kudla, Ryszard Bugno, Urszula Skupio, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 23, pp. 4434-4445
Open Access | Times Cited: 38
Novel Targets to Treat Depression: Opioid-Based Therapeutics
Caroline A. Browne, Moriah L. Jacobson, Irwin Lucki
Harvard Review of Psychiatry (2020) Vol. 28, Iss. 1, pp. 40-59
Closed Access | Times Cited: 34
Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder
Amanda B. Namchuk, Irwin Lucki, Caroline A. Browne
Advances in Drug and Alcohol Research (2022) Vol. 2
Open Access | Times Cited: 22
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors
Hildegard A. Wulf, Caroline A. Browne, Carlos A. Zarate, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2309-2316
Closed Access | Times Cited: 19
Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov
Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice
Iwona Filipczak-Bryniarska, Katarzyna Nazimek, Bernadeta Nowak, et al.
International Immunopharmacology (2017) Vol. 54, pp. 344-353
Closed Access | Times Cited: 32
Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory
Wen‐Ning Zhao, Balaram Ghosh, Marshall Tyler, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 9, pp. 2262-2273
Open Access | Times Cited: 29
Advances in novel molecular targets for antidepressants
Qingzhong Wang, Yogesh Dwivedi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110041-110041
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top